{"id":"W4400142790","doi":"10.1016/j.annonc.2024.05.192","title":"183P Lenvatinib versus sorafenib for recurrence of hepatocellular carcinoma after liver transplantation","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Sorafenib; Hepatocellular carcinoma; Liver transplantation; Oncology; Internal medicine; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000520309,0.0002658977,0.001072011,0.0002212374,0.0002348477,0.0006567939,0.0002546362,0.0003770518,0.003442271],"category_scores_gemma":[0.001112693,0.0001261292,0.001057135,0.0002376974,0.0002754256,0.0005608725,0.0003154694,0.001215606,0.0004460481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008646065,"about_ca_system_score_gemma":0.0007037098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009393396,"about_ca_topic_score_gemma":0.003060548,"domain_scores_codex":[0.9996949,0.00009948481,0.00002698876,0.00003192481,0.00003853248,0.0001082887],"domain_scores_gemma":[0.9996301,0.0001082684,0.00007846319,0.00002115501,0.00002100624,0.0001410753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4932317,0.002862133,0.0312972,0.001267793,0.0037917,0.001301235,0.0002138946,0.005639595,0.01193506,0.001143166,0.008214715,0.4391019],"study_design_scores_gemma":[0.1452506,0.3673866,0.3983607,0.0007881548,0.008450394,0.006935729,0.001230896,0.01748971,0.0159586,0.004909759,0.03296372,0.000275113],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886162,0.005348061,0.00019203,0.0009672416,0.000277659,0.00006167415,0.0002250079,0.00004207949,0.004269994],"genre_scores_gemma":[0.9970216,0.0009804334,0.0001310072,0.000274906,0.0001134442,0.00004135801,0.0002746411,0.000006328198,0.001156276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003442271,"threshold_uncertainty_score":0.0115155,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1991841643106293,"score_gpt":0.3632135857573097,"score_spread":0.1640294214466804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}